Driving the New Wave
of the Life Science Industry

2025

01

• Selected as a supplier for the consulting sector of the SME Innovation Voucher Support Program
• Launched 'Maven TMF', the digital clinical trial document management solution

2024

12

• Obtained Family-Friendly Company Certification 
• Signed an MOU with Hallym University and Chuncheon Sacred Heart Hospital 
• Signed an MOU with MICROT for FDA 510(k) Approval of A-Stream
• Signed an MOU with Foundation for Medical Innovation for Clinical Approvals and Investment in Pharmaceuticals and Medical Devices
• Signed an MOU with BS Research to Accelerate Clinical Research using Bio-compatible Surface Modification Technology and Global Expansion
• Signed an MOU with Kyung Hee University College of Pharmacy 

11

• Signed an MOU with Wonju Medical Device Techno Valley (WMIT) to advance Gangwon's medical device industry 

10

• Signed an MOU with Research Institute for Dementia(RID) to develope AI-based clinical solutions 

08

• Launched 'Maven Coder Express,' a generative AI-based medical coder
• Signed an MOU with Medirama to launch full-cycle service for oncology drug development
• Signed an MOU with Kangwon National University’s Industry-Academic Cooperation Foundation to activate the bio-innovation startup ecosystem and advance the global bio industry 

07

• Launched 'FDA Expert Solution,' a comprehensive FDA regulatory consulting service
• Signed an MOU with The University of Utah Asia Campus to promote the South Korea-U.S. pharmaceutical and biotech industry 
• Launched 'Maven VDR,' a Virtual Data Room tailored to the pharmaceutical and biotech industry

05

• First open recruitment for the GBP Clinical Operations field
• Signed an MOU with Korea University College of Pharmacy for education and research collaboration
• Signed an MOU with NEXTBIOMEDICAL for strengthening global competitiveness and technological collaboration
• Signed an MOU with CMAX Clinical Research (AU) for clinical trial business expansion 

04 

• Launched 'Maven Builder,' a Clinical Database Design Solution
• Signed an MOU with Chung-Ang University College of Pharmacy and Graduate School for industry-academia collaboration and talent development
• Established JNPMEDI Partners for an investment support program for innovative biotech and medical device companies

02 

• Signed an MOU with SOLUM Healthcare for development and commercialization of sensor-based rapid cancer diagnosis solution 
• Signed an MOU with Korea Innovation Medicine Consortium (KIMCo) for development of a global new drug R&D platform

2023

12

• Signed an MOU with Avance Clinical (AU)
• Launched 'Maven eRecruitment', an Online Clinical Trial Participant Recruitment Platform
  
  

11

• Signed an MOU with Yonsei University College of Pharmacy for research collaboration
  
  

09

• Selected for the Scale-up TIPS by Ministry of SMEs and Startups
  
  

07

• Signed an MOU with Kangbuk Samsung Hospital for establishing Smart Clinical Trial Center
  
  

05

• Launched 'Maven Safety,' a Pharmaceutical Safety Management Solution
  
  

04

• Obtained ISO/IEC 27701 Certification
  
  

02

• Obtained CDISC Platinum Membership
  
  

2022

12

• Secured Series A funding, including from Singapore's sovereign wealth fund
• Signed an MOU with Korea University Medical Center for clinical trial digitization
• Signed an MOU with ProSciento (U.S.A.) for solution expansion and service enhancement
  
  

11

• Signed contract with LSK Global PS for the use of 'Maven Docs'
• Implemented the enterprise analytics platform SAS Viya into 'Maven CDMS'
  
  

10

• Applied 'Maven DCT Suite' to Welt's Digital Insomnia Therapy
  
  

09

• Signed an MOU with Phantomics for collaborative development of a medical data platform and medical imaging AI software
  
  

08

• Signed an MOU with Mediaiplus for the activation of a global clinical trial data platform
  
  

04

• Selected for the TIPS by the Ministry of SMEs and Startups 
• Signed an MOU with Mediplexus for solution expansion and service enhancement
• Obtained ISO 27701/27799 Certification
  
  

03

• Launched 'Maven Docs,' a Clinical Trial Document Management Solution

01

• Enrolled in DTRA for the first in Korea
  
• Approved of Maven CDMS WHODrug B3/C3 for the first in Korea

2021

12

• Signed an MOU with SCL Healthcare for Maven-Central Lab integration services
• Secured 2 billion KRW in seed investment, including from Kakao Ventures
  
  

11

• Signed an MOU with LSK Global PS for advancement of a medical data platform
  
  

10

• Signed an MOU with Alchera for integration of AI image recognition technology and a medical data platform
  
  

04

• Launched, 'Maven CDMS,' Clinical Data Management System
• Signed an MOU with CHA Bundang Medical Center's Global Clinical Trials Center for new drug research and development
  
  

2020

07

• Founded JNPMEDI Inc.